Product Details

Mint-Montelukast

Montelukast Sodium
5 mg
Chewable Tablet


DIN/PIN/NPN

02408635

Manufacturer

Mint Pharmaceuticals Inc.

Formulary Listing Date

2014-01-03  

Unit Price

1.2075

Amount MOH Pays

1.2075

Coverage Status

Off-Formulary Interchangeable Exceptional Access Program Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

R03DC03

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02355515 Teva-Montelukast 1.2077 1.2077
02238216 Singulair NA NA
02330393 Sandoz Montelukast 1.2075 1.2075
02402807 Ran-Montelukast 1.2075 1.2075
02354985 PMS-Montelukast 1.2075 1.2075
02382466 Montelukast 1.2075 1.2075
02408635 Mint-Montelukast 1.2075 1.2075
02399873 Mar-Montelukast 1.2075 1.2075
02442361 Jamp-Montelukast 1.2075 1.2075
02422875 Auro-Montelukast Chewable Tablet 1.2077 1.2077
02377616 Apo-Montelukast 1.2075 1.2075
02514885 Jamp Montelukast Chewable Tablets 1.2075 1.2075
02379325 Montelukast 1.2075 1.2075
02522128 Nat-Montelukast 1.2077 1.2077
 

LU Clinical Criteria

NO  

EAP Criteria

Therapeutic Class Reimbursement Criteria
Asthma

Montelukast

  • Brand(s): Singulair
  • Dosage Form/Strength: 5 mg, 10 mg tablet
  • Updated criteria: October 28, 2010

For the treatment of asthma patients who cannot manage the use of an inhalation device despite assistance with a spacer (e.g., physically or mentally disabled patients or pediatric patients). 

Duration of Approval: 5 years

OR 

For the treatment of asthma in children and adolescents whose asthma cannot be controlled on ICS alone and where the condition remains uncontrolled despite using full doses of ICS with addition of LABA, and with assurance of good adherence and inhaler technique 

Duration of Approval: 5 years (up until age of 18) 

Renewal of requests that meet the above criteria will be provided where the following apply:

  • Current medications and dosages must be clearly specified; AND

  • Objective evidence of positive response from treatment (spirometry OR decrease in health care utilization) must be provided 

Duration of Approval: 5 years (up until age of 18)

EAP Drug Request Form:

Standard Form for EAP Drug Requests

Product Monograph

View Monograph